Feb 23, 2023
Article and Study Summary: A 24-week, All-Oral Regimen for Rifampin-Resistant Tuberculosis Published in: N Engl J Med. 2022;387(25):2331-2343. https://www.nejm.org/doi/full/10.1056/NEJMoa2117166 Authors: Nyang’wa B, Berry C, Kazounis E, et al. Summary This...Join our mailing list to receive the latest news and updates from our team.